Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori

Documenti analoghi

• Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori
  di: Ahmet UYGUN, et al.
  Pubblicazione: (2012-02-01)
• Concomitant and Bismuth Quadruple Therapy for <i>Helicobacter pylori</i> Eradication in Southern Italy: Preliminary Data from a Randomized Clinical Trial
  di: Giuseppe Losurdo, et al.
  Pubblicazione: (2024-04-01)
• Helicobacter pylori eradication rate following first line non-bismuth quadruple therapy regimen in Tunisian patients: the HPERAD study
  di: Monia Fekih, et al.
  Pubblicazione: (2025-12-01)
• Amoxicillin or tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori eradication: a systematic review and meta-analysis
  di: Kunping Ju, et al.
  Pubblicazione: (2025-09-01)
• Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy
  di: Engin ALTINTAŞ, et al.
  Pubblicazione: (2004-06-01)